<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04422067</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0295</org_study_id>
    <nct_id>NCT04422067</nct_id>
  </id_info>
  <brief_title>Usefulness of Cephalometry in the Second and Third Trimester of Pregnancy in the Diagnosis of Fetal Microretrognathia</brief_title>
  <official_title>Usefulness of Cephalometry in the Second and Third Trimester of Pregnancy in the Diagnosis of Fetal Microretrognathia : Prenatal Cephal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congenital retrognathia, with or without Pierre Robin Sequence (PRS), is a rare anomaly which
      can be associated with chromosomal abnormalities. Respiratory and feeding consequences can be
      present at birth. After birth, the diagnosis of retrognathia is based on the clinical
      examination. Cephalometry can be used to complete the diagnosis. Several authors have
      proposed the use of objective quantitative ultrasound parameters for the antenatal screening
      of PRS. In our study, the investigators evaluated fetal cephalometry.

      The aim First, the investigators studied the inter- and intra-observer reproducibility of
      cephalometry. Second, the investigators established reference values for antenatal
      cephalometry in normal fetuses. Third, the investigators compared the diagnostic performance
      of cephalometry and the other angles described in the literature for the diagnosis of
      retrognathia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reproducibility of cephalometry</measure>
    <time_frame>During ultrasound</time_frame>
    <description>Reproducibility of cephalometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perfomance of several angle to diagnose retrognatism</measure>
    <time_frame>During ultrasound</time_frame>
    <description>Perfomance of several angle to diagnose retrognatism</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">68</enrollment>
  <condition>Pierre Robin Sequence</condition>
  <arm_group>
    <arm_group_label>Case group (Retrognatism)</arm_group_label>
    <description>All pregnant patients with one or more fetuses suffering from a microretrognathia, diagnosed prenatally and integrated into a Pierre Robin Sequence, were included. All cases were confirmed postnatally, either by a pediatric examination or by a fetopathological examination in the case of a medical termination of the pregnancy. We had 21 cases.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>47 pregnant patients with fetus without facial abnormalities</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fetal cephalometry</intervention_name>
    <description>Fetal cephalometry</description>
    <arm_group_label>Case group (Retrognatism)</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All pregnant patients with one or more fetuses suffering from a microretrognathia,
        diagnosed prenatally and integrated into a Pierre Robin Sequence
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Pregnant patient (Aged &gt;18years old)

          -  with one or more fetuses suffering from a microretrognathia

          -  diagnosed prenatally

          -  integrated into a Pierre Robin Sequence

        Exclusion criteria:

          -  Uncvertain diagnosis

          -  Absence of 3D rendering volume
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florent FUCHS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 4, 2020</study_first_submitted>
  <study_first_submitted_qc>June 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>with one or more fetuses suffering from a microretrognathia</keyword>
  <keyword>Cephalometry</keyword>
  <keyword>Prenatal Diagnosis</keyword>
  <keyword>Facial angles</keyword>
  <keyword>Fetal echography</keyword>
  <keyword>Microretrognathia</keyword>
  <keyword>diagnosed prenatally</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pierre Robin Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

